Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081661566> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W3081661566 endingPage "S200" @default.
- W3081661566 startingPage "S200" @default.
- W3081661566 abstract "Background: Induced pluripotent stem cells (iPSCs) are promising candidates for regenerative cell-based therapies. Because autogenic iPSCs are not available for acute treatment procedures, allogeneic strategies have to be developed which evade immune rejection. We showed in this study that both mouse and human iPSCs lose their immunogenicity when major histocompatibility complex (MHC) class I and II genes are inactivated and CD47 is over-expressed. Methods: Hypoimmunogenic mouse (β2m-/-Ciita-/-Cd47tg miPSCs) and human (B2M-/-CIITA-/-CD47tg hiPSCs) iPSCs were generated via CRISPR/Cas9 technology and lentiviral overexpression. Unmodified and β2m-/-Ciita-/-Cd47tg miPSCs as well as their cell grafts were injected into syngeneic C57BL/6 or allogeneic BALB/c mice. Unmodified and B2M-/-CIITA-/-CD47tg hiPSCs and their cell grafts were injected into humanized mice. The cellular and antibody response was quantified and in vivo bioluminescence imaging were performed to assess cell survival. Results: FACS analysis showed normal expression of MHC I and MHC II on unmodified cells and depleted MHC I and MHC II on hypoimmunogenic cells. Surface expression of CD47 was 3-4 time increased in hypoimmunogenic cells compared to unmodified cells. After allogeneic transplantation, hypoimmunogenic cells showed a significantly decreased immune response in ELISPOT assays, comparable to the level of syngeneic transplants. No donor-specific antibodies were detected and the hypoimmunogenic cells were protected against innate response in in vivo innate cytotoxicity assays and in XCelligence assays. Additionally, 100% graft survival was achieved with hypoimmunogenic cells in vivo with an observation period of 50 days. Conclusion: Our results clearly demonstrate that the lack of immunogenicity is from MHC I and MHC II antigens and that the overexpression of the CD47 molecule prevents against innate immune responses. Thus, hypoimmunogenic iPSCs might serve as an unlimited cell source for the generation of universally compatible “off-the-shelf” cells grafts or tissues in future clinical applications." @default.
- W3081661566 created "2020-09-08" @default.
- W3081661566 creator A5000763253 @default.
- W3081661566 creator A5009560397 @default.
- W3081661566 creator A5012668274 @default.
- W3081661566 creator A5018865175 @default.
- W3081661566 creator A5025539602 @default.
- W3081661566 creator A5029888241 @default.
- W3081661566 creator A5040644146 @default.
- W3081661566 creator A5044628820 @default.
- W3081661566 creator A5046454314 @default.
- W3081661566 creator A5055004620 @default.
- W3081661566 creator A5061875137 @default.
- W3081661566 creator A5076167190 @default.
- W3081661566 creator A5077281667 @default.
- W3081661566 date "2020-09-01" @default.
- W3081661566 modified "2023-10-18" @default.
- W3081661566 title "HYPOIMMUNOGENIC DERIVATIVES OF INDUCED PLURIPOTENT STEM CELLS EVADE IMMUNE REJECTION IN FULLY IMMUNOCOMPETENT ALLOGENEIC RECIPIENTS" @default.
- W3081661566 doi "https://doi.org/10.1097/01.tp.0000699400.43643.30" @default.
- W3081661566 hasPublicationYear "2020" @default.
- W3081661566 type Work @default.
- W3081661566 sameAs 3081661566 @default.
- W3081661566 citedByCount "0" @default.
- W3081661566 crossrefType "journal-article" @default.
- W3081661566 hasAuthorship W3081661566A5000763253 @default.
- W3081661566 hasAuthorship W3081661566A5009560397 @default.
- W3081661566 hasAuthorship W3081661566A5012668274 @default.
- W3081661566 hasAuthorship W3081661566A5018865175 @default.
- W3081661566 hasAuthorship W3081661566A5025539602 @default.
- W3081661566 hasAuthorship W3081661566A5029888241 @default.
- W3081661566 hasAuthorship W3081661566A5040644146 @default.
- W3081661566 hasAuthorship W3081661566A5044628820 @default.
- W3081661566 hasAuthorship W3081661566A5046454314 @default.
- W3081661566 hasAuthorship W3081661566A5055004620 @default.
- W3081661566 hasAuthorship W3081661566A5061875137 @default.
- W3081661566 hasAuthorship W3081661566A5076167190 @default.
- W3081661566 hasAuthorship W3081661566A5077281667 @default.
- W3081661566 hasBestOaLocation W30816615661 @default.
- W3081661566 hasConcept C104317684 @default.
- W3081661566 hasConcept C107459253 @default.
- W3081661566 hasConcept C141071460 @default.
- W3081661566 hasConcept C145103041 @default.
- W3081661566 hasConcept C203014093 @default.
- W3081661566 hasConcept C207936829 @default.
- W3081661566 hasConcept C2775890610 @default.
- W3081661566 hasConcept C2776090121 @default.
- W3081661566 hasConcept C2778814158 @default.
- W3081661566 hasConcept C2779053233 @default.
- W3081661566 hasConcept C2911091166 @default.
- W3081661566 hasConcept C502942594 @default.
- W3081661566 hasConcept C55493867 @default.
- W3081661566 hasConcept C71924100 @default.
- W3081661566 hasConcept C86803240 @default.
- W3081661566 hasConcept C8891405 @default.
- W3081661566 hasConceptScore W3081661566C104317684 @default.
- W3081661566 hasConceptScore W3081661566C107459253 @default.
- W3081661566 hasConceptScore W3081661566C141071460 @default.
- W3081661566 hasConceptScore W3081661566C145103041 @default.
- W3081661566 hasConceptScore W3081661566C203014093 @default.
- W3081661566 hasConceptScore W3081661566C207936829 @default.
- W3081661566 hasConceptScore W3081661566C2775890610 @default.
- W3081661566 hasConceptScore W3081661566C2776090121 @default.
- W3081661566 hasConceptScore W3081661566C2778814158 @default.
- W3081661566 hasConceptScore W3081661566C2779053233 @default.
- W3081661566 hasConceptScore W3081661566C2911091166 @default.
- W3081661566 hasConceptScore W3081661566C502942594 @default.
- W3081661566 hasConceptScore W3081661566C55493867 @default.
- W3081661566 hasConceptScore W3081661566C71924100 @default.
- W3081661566 hasConceptScore W3081661566C86803240 @default.
- W3081661566 hasConceptScore W3081661566C8891405 @default.
- W3081661566 hasIssue "S3" @default.
- W3081661566 hasLocation W30816615661 @default.
- W3081661566 hasLocation W30816615662 @default.
- W3081661566 hasLocation W30816615663 @default.
- W3081661566 hasLocation W30816615664 @default.
- W3081661566 hasLocation W30816615665 @default.
- W3081661566 hasLocation W30816615666 @default.
- W3081661566 hasOpenAccess W3081661566 @default.
- W3081661566 hasPrimaryLocation W30816615661 @default.
- W3081661566 hasRelatedWork W1970289093 @default.
- W3081661566 hasRelatedWork W1988241479 @default.
- W3081661566 hasRelatedWork W1995548077 @default.
- W3081661566 hasRelatedWork W2079386034 @default.
- W3081661566 hasRelatedWork W2166919567 @default.
- W3081661566 hasRelatedWork W2399536512 @default.
- W3081661566 hasRelatedWork W2528173482 @default.
- W3081661566 hasRelatedWork W2565718505 @default.
- W3081661566 hasRelatedWork W4286856427 @default.
- W3081661566 hasRelatedWork W4313383814 @default.
- W3081661566 hasVolume "104" @default.
- W3081661566 isParatext "false" @default.
- W3081661566 isRetracted "false" @default.
- W3081661566 magId "3081661566" @default.
- W3081661566 workType "article" @default.